Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
申请人:TORRENT PHARMACEUTICALS LTD.
公开号:US20030092744A1
公开(公告)日:2003-05-15
The invention discloses novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and discoloration of teeth, by breaking preformed AGE, of the general formula I, or pharmaceutically acceptable salts thereof,
1
wherein, R
1
, R
2
, R
3
, X and m are as defined in the specification.
The invention also discloses, method for preparation of the novel compounds of the series and pharmaceutical composition having one or more compounds as defined above as active ingredients.
The invention further discloses a method of treatment of a diabetic patient by administering the compounds as defined above, either singly or in combination with drugs for antidiabetic therapy.
本发明公开了新型吡啶系列化合物,通过打破通式 I 的预形成 AGE 或其药学上可接受的盐,可用于治疗糖尿病和与衰老相关的血管并发症,包括肾病、神经损伤、动脉粥样硬化、视网膜病变、皮肤病和牙齿变色、
1
其中,R
1
, R
2
, R
3
X 和 m 如说明书中所定义。
本发明还公开了本系列新型化合物的制备方法和以一种或多种如上定义的化合物为活性成分的药物组合物。
本发明进一步公开了一种治疗糖尿病患者的方法,通过单独施用或与抗糖尿病治疗药物联合施用上述定义的化合物。